Here are some examples of what research has shown about taking MVMs to increase nutrient intakes, improve health, and reduce the risk of disease.
Increase nutrient intakes
Taking an MVM increases the amounts of nutrients you get each day. This can help you get recommended amounts of vitamins and minerals when you cannot or do not get enough of them from food alone. But taking an MVM can also raise the chances of getting too much of some nutrients, such as iron, vitamin A, zinc, niacin, and folic acid, especially if you take a product that contains more than the recommended amounts of some nutrients.
Some people take an MVM as a form of dietary or nutritional insurance. Yet people who take MVMs often consume more vitamins and minerals from food and beverages than those who don’t.
Health promotion and chronic disease prevention
It is difficult to determine whether MVMs provide health benefits because studies often use different products, making it hard to compare their results. Also, many MVMs are available, and manufacturers can change their composition at will, so it’s hard for researchers to study whether specific combinations of vitamins and minerals affect health. Also, people with healthier diets and lifestyles are more likely to take MVMs, making it hard to identify any benefits from the products alone.
Scientists have studied whether taking MVMs affects the risk of health problems and diseases such as cancer, heart disease, osteoporosis, lung disorders, psychiatric disorders, and the risk of death. Most studies have found that taking MVMs has little or no effect on these health outcomes.
Cancer
Overall, it’s unclear whether taking an MVM affects cancer risk.
One large study found that male physicians aged 50 and older who took a basic MVM for about 11 years had a slightly reduced risk of developing cancer—but not of dying of the disease—compared with those who took a placebo. In another large study in men and women ages 60–65 years and older, those who took a basic MVM for about 3.6 years did not have a lower risk of developing cancer, except for lung cancer. Other studies found conflicting evidence. For example, various studies have found that MVMs might increase, decrease, or not affect the risk of breast cancer in women. Some studies suggest MVMs might reduce the risk of colon cancer, but increase the risk of prostate cancer, lung cancer, and leukemia in men.
Cardiovascular disease (CVD)
Overall, MVMs appear to have little or no effect on the risk of CVD.
Most studies in men and women comparing MVMs to a placebo have found that the MVMs do not reduce the risk of CVD, including heart attacks or strokes or resulting deaths. Most other studies of people who take MVMs on their own have found that these products do not protect against CVD either.
Cataracts and age-related macular degeneration (AMD)
A specific combination of vitamins and minerals can slow down vision loss from AMD, an eye disease that can blur your central vision.
The Age-Related Eye Disease Study (AREDS) showed that people with AMD and/or cataracts who took a daily supplement of high-dose vitamin C (500 mg), vitamin E (400 IU), beta-carotene (15 mg), zinc (80 mg), and copper (2 mg) for about 6 years had a lower chance of developing advanced AMD. They also had less vision loss than those who did not take the supplement. However, the supplements did not reduce the risk of getting AMD or the risk of cataracts. A later study showed that the supplement was equally effective without beta-carotene.
Pregnancy and birth outcomes
Prenatal MVM supplements can help a pregnant person get enough nutrients, especially key nutrients such as folic acid and iron. Pregnant people who are at risk of malnutrition might be less likely to have a baby that is premature or has a low birth weight or small size if they take an MVM during pregnancy. But for pregnant people who already get enough of all nutrients, MVMs might not make any difference.
Other outcomes
Several studies have examined the link between MVM use and conditions such as osteoporosis, lung diseases, psychiatric disorders, and even risk of death. Most found that MVMs have no effect on these health outcomes. One study found that MVM use for three years in older people (average age 73 years) improved cognitive function, memory, and related mental skills.